GREENLAND MINES LTD Weighted Average Number of Shares, Contingently Issuable
GREENLAND MINES LTD (GRML) had Weighted Average Number of Shares, Contingently Issuable of 2.98 million shares as of 2024-11-06, per its 10-K/A filed 2026-08-14.
Financial Statements › Notes
us-gaap:WeightedAverageNumberOfSharesContingentlyIssuable · last filed 2026-08-14
- 2024-11-06: Weighted Average Number of Shares, Contingently Issuable 2.98M shares.
- 2023-11-04: Weighted Average Number of Shares, Contingently Issuable 2.98M shares.
| Period end | Weighted Average Number of Shares, Contingently Issuable |
|---|---|
| 2024-11-06 | 2.98M shares 10-K/A · filed 2026-08-14 |
| 2023-11-04 | 2.98M shares 10-K · filed 2025-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |